Literature DB >> 27966178

Long-term efficacy and safety of tension free vaginal tape in a historic cohort of 463 women with stress urinary incontinence.

Armand Chevrot1, Stéphane Droupy2, Gregoire Coffin2, Laurent Soustelle2, Michel Boukaram2, Brigitte Fatton3, Renaud de Tayrac3, Laurent Wagner2, Pierre Costa2.   

Abstract

INTRODUCTION AND HYPOTHESIS: We report retrospective data on the long-term safety and efficacy of the retropubic midurethral sling (MUS) in a large series of women with stress urinary incontinence.
METHODS: In all, 517 patients were treated during the period January 2005 to June 2012 at a single centre in France. The Urinary Symptoms Profile score was used to identify women who were subjectively cured or improved or in whom treatment had failed. The rates of peroperative, and early (<30 days) and late postoperative complications were recorded.
RESULTS: A total of 463 patients were evaluable at a mean (±SD) follow-up of 71 ± 23 months. At the last follow-up, 344 patients (74.3 %) demonstrated subjective cure, 55 (11.9 %) were improved and 64 (13.8 %) had treatment failure. Bladder perforations occurred in 33 patients (7.1 %); however, this had no effect on cure rate. In the early postoperative period, temporary intermittent self-catheterization was required in 10 patients (2.2 %) due to voiding difficulties. The most frequent long-term postoperative complication was de novo urge incontinence that was reported by 59 patients (12.7 %); seven patients (1.5 %) needed tape excision due to voiding difficulties and six (1.3 %) needed tape removal due to erosion or chronic pain.
CONCLUSIONS: The retropubic MUS was shown to be durable at a mean follow-up of 71 ± 23 months, with a high success/improvement rate and no serious long-term tape-induced adverse effects.

Entities:  

Keywords:  Longterm adverse effect; Suburethral slings; Treatment outcome; Urinary incontinence, stress

Mesh:

Year:  2016        PMID: 27966178     DOI: 10.1007/s00192-016-3230-2

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  28 in total

1.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Authors:  Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Results of the tension-free vaginal tape procedure for treatment of female stress urinary incontinence: a 5-year follow-up study.

Authors:  Ibrahim Celebi; Kemal Güngördük; Cemal Ark; Alpaslan Akyol
Journal:  Arch Gynecol Obstet       Date:  2008-09-18       Impact factor: 2.344

Review 3.  An integral theory of female urinary incontinence. Experimental and clinical considerations.

Authors:  P E Petros; U I Ulmsten
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1990

Review 4.  Mid-urethral sling operations for stress urinary incontinence in women.

Authors:  Abigail A Ford; Lynne Rogerson; June D Cody; Joseph Ogah
Journal:  Cochrane Database Syst Rev       Date:  2015-07-01

5.  Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence.

Authors:  C G Nilsson; N Kuuva; C Falconer; M Rezapour; U Ulmsten
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

6.  Vascular injury during tension-free vaginal tape procedure for stress urinary incontinence.

Authors:  M D Walters; P K Tulikangas; C LaSala; T W Muir
Journal:  Obstet Gynecol       Date:  2001-11       Impact factor: 7.661

Review 7.  Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women.

Authors:  Evangelia Bakali; Brian S Buckley; Paul Hilton; Douglas G Tincello
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

8.  A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence.

Authors:  U Ulmsten; C Falconer; P Johnson; M Jomaa; L Lannér; C G Nilsson; I Olsson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

9.  Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial.

Authors:  Matthew D Barber; Steven Kleeman; Mickey M Karram; Marie Fidela R Paraiso; Mark D Walters; Sandip Vasavada; Mark Ellerkmann
Journal:  Obstet Gynecol       Date:  2008-03       Impact factor: 7.661

10.  Both the middle and distal sections of the urethra may be regarded as optimal targets for 'outside-in' transobturator tape placement.

Authors:  Michał Bogusiewicz; Marta Monist; Krzysztof Gałczyński; Magdalena Woźniak; Andrzej P Wieczorek; Tomasz Rechberger
Journal:  World J Urol       Date:  2014-02-17       Impact factor: 4.226

View more
  5 in total

1.  Complications and re-operations after tension-free vaginal tape operation in women with stress urinary incontinence.

Authors:  Nikoline Buus Søgaard; Karin Glavind
Journal:  Int Urogynecol J       Date:  2020-07-02       Impact factor: 2.894

2.  Management of mid-urethral tape complications: a retrospective study.

Authors:  Ifeoma Offiah; Suneetha Rachaneni; Anupreet Dua
Journal:  J Obstet Gynaecol India       Date:  2019-09-07

3.  Functional outcomes of vaginal surgery for urethral extrusion of mid-urethral tape in women.

Authors:  Bogdan Toia; Stephen Unterberg; Neha Sihra; Mahreen Pakzad; Rizwan Hamid; Jeremy L Ockrim; Tamsin J Greenwell
Journal:  Int Urogynecol J       Date:  2021-04-06       Impact factor: 1.932

Review 4.  Contemporary diagnostics and treatment options for female stress urinary incontinence.

Authors:  Allert M de Vries; John P F A Heesakkers
Journal:  Asian J Urol       Date:  2017-09-14

5.  Intraoperative and early postoperative complications in women with stress urinary incontinence treated with suburethral slings: a randomised trial.

Authors:  Jacek K Szymański; Kornelia Zaręba; Grzegorz Jakiel; Aneta Słabuszewska-Jóźwiak
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-04-29       Impact factor: 1.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.